Meticulous Research®—a leading global market research company, published a research report titled, ‘Clinical Lab Automation Market by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, Automated ELISA, Software), End User (Hospital Laboratories, Diagnostic Laboratories) – Global Forecast to 2030.’
Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5762?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=16-01-2024
According to this latest publication from Meticulous
Research®, the global clinical lab automation market is projected to reach
$3.72 billion by 2030, at a CAGR of 7.8%. The growth of this market can be
attributed to the rising global geriatric population, the increasing prevalence
of infectious diseases, and technological advancements in clinical laboratory
instruments. However, the high costs of advanced clinical lab automation
equipment, coupled with funding and infrastructure limitations in developing countries,
restrain the growth of this market.
Furthermore, the increasing demand for automated
instruments, technological advancements in molecular diagnostics, and emerging
economies are expected to create market growth opportunities. However, factors
such as high equipment maintenance and repair costs and concerns over the
security and privacy of patient data pose challenges for the market’s growth.
Browse in depth @ https://www.meticulousresearch.com/product/clinical-lab-automation-market-5762?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=16-01-2024
Key Players
The key players profiled in the clinical lab automation
market report are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories,
Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as
PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent
Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd.
(Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and
Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and
Hamilton Company (U.S.).
The global clinical lab automation market is segmented by
Product (systems {automated liquid handling systems, automated ELISA systems,
automated nucleic acid purification systems, automated microplate readers, and
other systems} and clinical lab automation software), End user (hospital
laboratories, diagnostic laboratories, and other end users), and Geography. The
study also evaluates industry competitors and analyzes their market share at
the global and regional levels.
Speck to our analyst @
https://www.meticulousresearch.com/speak-to-analyst/cp_id=5762?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=16-01-2024
Based on product, in 2023, the systems segment is expected
to account for the largest share of the market. The large market share of this
segment is attributed to the benefits of clinical lab automation systems, which
facilitate procedures without manual intervention, enhancing laboratory testing
capabilities. These systems mitigate repetitive tasks and errors, resulting in
increased throughput and efficiency, ultimately improving the quality of test
results.
Based on end user, in 2023, the hospital laboratories
segment is expected to account for the largest share of the market. The large
share of the segment is attributed to factors such as rising healthcare
expenditure, increasing prevalence of chronic diseases, increasing sample loads
in hospitals, and improving healthcare infrastructure in developing countries.
Request Free Research Report Sample @ https://www.meticulousresearch.com/request-sample-report/cp_id=5762?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=16-01-2024
Geographic Review
This research report analyzes major geographies and provides
a comprehensive analysis of the market in North America (U.S., Canada), Europe
(Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific
(China, Japan, India, and the Rest of Asia-Pacific), Latin America and the
Middle East & Africa. In 2022, North America is expected to account for the
largest share of the clinical lab automation market, followed by Europe.
However, Asia Pacific is slated to register the largest CAGR during the forecast
period. The growth of this market is primarily driven by the increasing
investment by healthcare providers towards infrastructure improvement, the need
to manage the growing burden of infectious diseases, the rising demand for
clinical testing, supportive government initiatives to improve the
accessibility to diagnostic services, and the need to establish more diagnostic
laboratories.
